The normalization of the ultrastructure and oxidative phosphorylation of skeletal muscle mitochondria by alisporivir treatment in diabetes mellitus can be attributed to its effect on the signaling systems responsible for mitochondrial biogenesis (PGC1-α) and mitochondrial dynamics (mitofusin 2 and DRP1). This evidence concerns the gene PPARGC1A and diabetes mellitus.